We break down NSE IPO valuation against global peers, flag the derivatives risk, and explain why waiting might beat applying on day one.
A stock exchange is a strange thing to own. It does not make cars or software. It sells a seat at the table where India's savings meet India's businesses. Last month the National Stock Exchange told bankers it wants roughly $46 billion for that seat, according to reporting from the Wall Street Journal. That single number now sits at the center of every dinner-table argument about whether retail investors should apply.
Here is the uncomfortable part. At $46 billion, NSE would list as one of the most expensive exchanges on earth, measured against the profits it actually earns. Whether that is madness or fair value depends on a question most IPO coverage skips: what exactly are you buying when you buy an exchange?
## What NSE actually earns
NSE makes money in three main buckets.
- **Transaction fees.** Every trade on its equity and derivatives platforms pays a tiny toll. This is the bulk of revenue.
- **Data and connectivity.** Brokers, funds and algo shops pay for real-time feeds, historical data and co-location racks.
- **Listing and compliance fees.** Companies pay annually to stay listed.
The catch is that the derivatives franchise, not cash equities, drives the profit. NSE handles the overwhelming majority of India's exchange-traded derivatives, and those contracts turn over at volumes that make global peers blink. That dominance is the entire bull case. It is also the entire risk, because regulators have been steadily squeezing the economics of that franchise.
## The valuation math, in plain numbers
NSE does not publish quarterly numbers the way a listed company does, so we work with the last full-year disclosures and the price the IPO implies. On those figures, $46 billion works out to roughly 40 to 45 times trailing earnings, depending on which profit line you trust.
Put that next to the global club:
| Exchange | Rough P/E | Home market |
|---|---|---|
| NSE (IPO ask) | 40 to 45x | India |
| Hong Kong Exchanges | 30 to 35x | Hong Kong |
| London Stock Exchange Group | 25 to 30x | UK |
| Nasdaq Inc | 25 to 30x | US |
| Deutsche Boerse | 18 to 22x | Germany |
Read that table slowly. NSE is asking a premium to every major listed exchange in the world, including the one that runs the Nasdaq. The usual defense is growth: India's equity participation is rising, SIP inflows keep setting records, and NSE sits at the toll booth. Fair. But a premium multiple means you are paying today for growth that has to actually arrive, on schedule, for years.
## Why the derivatives squeeze matters
In 2024 the Securities and Exchange Board of India tightened index derivatives rules. Higher contract sizes, fewer weekly expiries, steeper STT. The stated goal was protecting retail traders from themselves. The side effect is that NSE's most profitable product line now faces a structural headwind, not a cyclical one.
We think the market is underpricing this. When your top revenue engine is one regulatory circular away from a haircut, you do not deserve the same multiple as a diversified data-and-clearing business. The London Stock Exchange, for instance, earns heavily from data and post-trade services, which are stickier and less politically exposed. That is part of why it trades cheaper despite a longer track record.
### The bull case, stated honestly
- India's demat accounts have roughly tripled in five years. That runway is real.
- NSE's derivatives liquidity is genuinely hard to replicate. BSE competes, but the depth gap remains wide.
- Exchanges are asset-light. Incremental volume costs almost nothing to serve.
- A listed NSE becomes acquisition currency and can pay real dividends.
### The bear case, stated just as honestly
- The IPO price already bakes in years of flawless execution.
- SEBI has shown it will act when retail losses mount, and derivatives are where those losses live.
- Competition from BSE is no longer theoretical.
- You are buying a minority stake with no control over fees, rules or strategy.
- Anchor investors get in cheaper than you will. That gap is your starting loss.
## Our take
If you want exchange exposure in an Indian portfolio, we would rather own the listed incumbent at a sane multiple than chase the flashy new listing. BSE has already re-rated hard, so it is not a bargain either, but its valuation still leaves room for error. Among global names, Hong Kong Exchanges and Clearing offers comparable Asian growth at a visibly lower price, and Nasdaq Inc gives you the data and listing annuity without single-regulator risk.
Our practical recommendations:
1. **Do not apply for the NSE IPO on day one at $46 billion.** Wait for the first two quarters of listed disclosures. You will pay a small premium for certainty and skip the [anchor-investor discount](/finance/blog/anchor-investors-in-ipos-what-they-signal-for-retail-investors) problem entirely.
2. **If you must own it, cap it at 2 to 3 percent of your equity allocation.** This is a single-country, single-regulator bet.
3. **For diversified exposure, use a broad India index fund instead.** You get NSE's growth indirectly through the brokers and depository participants that profit from the same volumes, without the concentration.
One more thing, and this is the tax-aware part. Indian IPOs held under a year attract short-term capital gains tax at your slab rate. Hold past twelve months and you pay long-term rates, currently 12.5 percent above the exemption threshold for listed equity. If you are buying NSE as a trade, budget for the tax drag. If you are buying it as a ten-year holding, the entry price matters far more than the listing-day pop.
## FAQ
**Is the NSE IPO price of $46 billion justified?**
It implies a P/E of roughly 40 to 45 times, a premium to every major global exchange. Justified only if derivatives volumes keep compounding and regulation stays friendly. Both are uncertain.
**Can Indian retail investors apply for the NSE IPO?**
Yes, subject to the usual retail quota and lot size rules set out in the red herring prospectus. Check the UPI mandate limits before you bid, since exchange IPOs often carry large minimum lots.
**What is the biggest risk in the NSE IPO analysis?**
Regulatory risk on derivatives. SEBI has already cut into the most profitable product line once, and nothing prevents a second round.
Frequently asked questions
Is the NSE IPO price of $46 billion justified?
It implies a P/E of roughly 40 to 45 times, a premium to every major global exchange. Justified only if derivatives volumes keep compounding and regulation stays friendly. Both are uncertain.
Can Indian retail investors apply for the NSE IPO?
Yes, subject to the usual retail quota and lot size rules set out in the red herring prospectus. Check the UPI mandate limits before you bid, since exchange IPOs often carry large minimum lots.
What is the biggest risk in the NSE IPO analysis?
Regulatory risk on derivatives. SEBI has already cut into the most profitable product line once, and nothing prevents a second round.
YourMoneyWise
